SELLAS Life Sciences Group (SLS) Short Interest Ratio & Short Volume $1.23 -0.02 (-1.21%) (As of 10:21 AM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends SELLAS Life Sciences Group Short Interest DataSELLAS Life Sciences Group (SLS) has a short interest of 8.61 million shares. This marks a 41.61% increase in short interest from the previous month. The short interest ratio (days to cover) is 16.1, indicating that it would take 16.1 days of the average trading volume of 1.07 million shares to cover all short positions.Current Short Interest8,610,000 sharesPrevious Short Interest6,080,000 sharesChange Vs. Previous Month+41.61%Dollar Volume Sold Short$10.16 millionShort Interest Ratio16.1 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares70,380,000 sharesPercentage of Shares Shorted12.23%Today's Trading Volume219,417 sharesAverage Trading Volume1,069,745 sharesToday's Volume Vs. Average21% Short Selling SELLAS Life Sciences Group? Sign up to receive the latest short interest report for SELLAS Life Sciences Group and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSLS Short Interest Over TimeSLS Days to Cover Over TimeSLS Percentage of Float Shorted Over Time Ad Angel PublishingTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.Click here to get the details. SELLAS Life Sciences Group Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20248,610,000 shares $10.16 million +41.6%N/A16.1 $1.18 10/15/20246,080,000 shares $7.30 million -25.7%N/A10.2 $1.20 9/30/20248,180,000 shares $10.23 million +0.3%N/A13 $1.25 9/15/20248,160,000 shares $10.77 million -0.7%N/A12.4 $1.32 8/31/20248,220,000 shares $10.60 million +6.5%N/A9.2 $1.29 8/15/20247,720,000 shares $9.80 million -27.5%N/A8.4 $1.27 Get the Latest News and Ratings for SLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SELLAS Life Sciences Group and its competitors with MarketBeat's FREE daily newsletter. 7/31/202410,650,000 shares $12.35 million +9.6%N/A11 $1.16 7/15/20249,720,000 shares $10.59 million +9.7%N/A8.3 $1.09 6/30/20248,860,000 shares $10.54 million +17.4%N/A7.2 $1.19 6/15/20247,550,000 shares $11.33 million -1.3%N/A5.2 $1.50 5/31/20247,650,000 shares $10.79 million +5.5%N/A5.3 $1.41 5/15/20247,250,000 shares $10.66 million +3.7%N/A4.7 $1.47 4/30/20246,990,000 shares $8.67 million +23.3%N/A4.6 $1.24 4/15/20245,670,000 shares $7.54 million +7.6%N/A4 $1.33 3/31/20245,270,000 shares $5.32 million +1.7%N/A3.6 $1.01 3/15/20245,180,000 shares $5.70 million +14.9%N/A3.7 $1.10 2/29/20244,510,000 shares $4.56 million +15.9%N/A4.2 $1.01 2/15/20243,890,000 shares $2.74 million +24.7%N/A3.7 $0.70 1/31/20243,120,000 shares $2.00 million -19.6%N/A3.1 $0.64 1/15/20243,880,000 shares $2.07 million -18.0%N/A4.3 $0.53 12/31/20234,730,000 shares $5.01 million +1.5%N/A4.9 $1.06 12/15/20234,660,000 shares $5.36 million +1.1%N/A6.3 $1.15 11/30/20234,610,000 shares $4.79 million +0.7%N/A7.3 $1.04 11/15/20234,580,000 shares $4.44 million +50.2%N/A8.7 $0.97 10/31/20233,050,000 shares $2.96 million +49.5%N/A6.6 $0.97 10/15/20232,040,000 shares $2.65 million +87.2%N/A6.5 $1.30 9/30/20231,090,000 shares $1.79 million +6.9%N/A7.7 $1.64 9/15/20231,020,000 shares $1.64 million -9.7%N/A8.1 $1.61 8/31/20231,130,000 shares $1.66 million No ChangeN/A8.9 $1.47 8/15/20231,130,000 shares $1.68 million -4.2%N/A8.7 $1.49 7/31/20231,180,000 shares $1.94 million +2.6%N/A8.2 $1.64 7/15/20231,150,000 shares $1.97 million -0.9%N/A7.4 $1.71 6/30/20231,160,000 shares $1.82 million +3.6%N/A6.8 $1.57 6/15/20231,120,000 shares $1.86 million -5.9%N/A5.4 $1.66 5/31/20231,190,000 shares $2.04 million -4.8%N/A4.8 $1.72 5/15/20231,250,000 shares $2.05 million +4.2%N/A2.7 $1.64 4/30/20231,200,000 shares $1.69 million +1.7%N/A2.6 $1.41 4/15/20231,180,000 shares $1.89 million +7.3%N/A2.6 $1.60 3/31/20231,100,000 shares $1.57 million -9.8%N/A2.4 $1.43 3/15/20231,220,000 shares $1.68 million -5.4%N/A3 $1.38Trump said you could learn something from this man (Ad)Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement. Here’s everything you need to know. 2/28/20231,290,000 shares $2.18 million +7.5%N/A3.5 $1.69 2/15/20231,200,000 shares $3.79 million +2.6%N/A4.1 $3.16 1/31/20231,170,000 shares $3.88 million -2.5%N/A4.5 $3.32 1/15/20231,200,000 shares $3.41 million -3.2%N/A3.6 $2.84 12/30/20221,240,000 shares $2.93 million +0.8%N/A3.3 $2.36 12/15/20221,230,000 shares $2.85 million +1.7%N/A3.4 $2.32 11/30/20221,210,000 shares $2.89 million +5.2%N/A3.3 $2.39 11/15/20221,150,000 shares $2.58 million +15.4%N/A3.3 $2.24 10/31/2022996,800 shares $4.67 million +21.3%N/A3.8 $4.68 10/15/2022822,000 shares $1.57 million -0.9%N/A4.5 $1.91 9/30/2022829,600 shares $1.68 million -0.7%N/A8.3 $2.02 9/15/2022835,100 shares $2.51 million +0.1%N/A7.8 $3.00 8/31/2022834,400 shares $2.55 million -6.1%N/A7.1 $3.06 8/15/2022888,700 shares $2.88 million +5.9%N/A6.6 $3.24 7/31/2022838,900 shares $2.15 million -2.3%N/A5.4 $2.56 7/15/2022858,900 shares $2.16 million -4.1%N/A5.3 $2.52 6/30/2022895,600 shares $2.00 million -0.3%N/A4.7 $2.23 6/15/2022897,800 shares $2.22 million +6.0%N/A3 $2.47 5/31/2022847,000 shares $2.58 million -10.1%N/A3 $3.05 5/15/2022942,500 shares $2.51 million +8.6%N/A3.4 $2.66 4/30/2022867,800 shares $2.36 million -5.2%N/A3.5 $2.72 4/15/2022915,500 shares $3.22 million -8.5%N/A3.5 $3.52 3/31/20221,000,000 shares $6.68 million No ChangeN/A4 $6.68 3/15/20221,000,000 shares $5.38 million +1.2%N/A7.3 $5.38 2/28/2022988,000 shares $6.03 million -1.1%N/A7 $6.10 2/15/2022999,200 shares $6.48 million +1.3%N/A7.1 $6.49 1/31/2022986,700 shares $5.27 million +15.4%N/A5.8 $5.34 1/15/2022854,700 shares $4.73 million +10.0%N/A5.6 $5.53 12/31/2021776,800 shares $4.30 million -2.4%N/A5.1 $5.53 12/15/2021796,100 shares $5.10 million +9.6%N/A5.1 $6.40 11/30/2021726,200 shares $4.89 million +11.8%N/A4.4 $6.74 11/15/2021649,600 shares $4.85 million -3.5%N/A3.7 $7.47 10/29/2021672,900 shares $5.85 million -22.1%N/A3.7 $8.69 10/15/2021863,200 shares $7.62 million +4.1%N/A4.3 $8.83 9/30/2021829,200 shares $7.60 million +7.2%N/A3.6 $9.16 9/15/2021773,700 shares $7.78 million -14.2%N/A1.7 $10.05 8/31/2021901,200 shares $8.37 million -23.6%N/A1.8 $9.29 8/13/20211,180,000 shares $11.88 million No ChangeN/A2 $10.07 7/30/20211,180,000 shares $10.10 million +4.4%N/A2 $8.56 7/15/20211,130,000 shares $9.75 million +28.9%N/A1.9 $8.63 6/30/2021876,900 shares $9.73 million +27.3%N/A1.5 $11.10 6/15/2021688,900 shares $7.89 million -10.9%N/A1.4 $11.45 5/28/2021773,400 shares $9.25 million -15.2%N/A1.5 $11.96 5/14/2021911,600 shares $0.00 +1.2%6.1%1.7 $0.00 4/30/2021901,100 shares $7.22 million -4.2%6.1%1.4 $8.01 4/15/2021940,100 shares $7.76 million +20.2%6.3%0.5 $8.25 3/31/2021782,300 shares $6.27 million -8.2%5.3%0.4 $8.02 3/15/2021852,100 shares $8.74 million +5.9%6.1%0.4 $10.26 2/26/2021805,000 shares $6.74 million -16.2%5.8%0.1 $8.37 2/12/2021960,400 shares $8.85 million +5.2%6.9%0.2 $9.21Trump said you could learn something from this man (Ad)Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement. Here’s everything you need to know. 1/29/2021912,700 shares $5.02 million +43.4%8.1%0.2 $5.50 1/15/2021636,300 shares $3.85 million -15.4%5.6%0.2 $6.05 12/31/2020752,000 shares $4.39 million -40.3%6.7%0.2 $5.84 12/15/20201,260,000 shares $8.43 million +127.5%11.3%0.3 $6.69 11/30/2020553,900 shares $2.06 million +51.1%6.2%1.3 $3.72 11/15/2020366,600 shares $964,158.00 -11.1%4.1%2.3 $2.63 10/30/2020412,200 shares $1.08 million -0.1%4.6%2.9 $2.63 10/15/2020412,500 shares $1.10 million -1.6%4.6%2.1 $2.66 SLS Short Interest - Frequently Asked Questions What is SELLAS Life Sciences Group's current short interest? Short interest is the volume of SELLAS Life Sciences Group shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 8,610,000 shares of SLS short. Learn More on SELLAS Life Sciences Group's current short interest. What is a good short interest ratio for SELLAS Life Sciences Group? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SLS shares currently have a short interest ratio of 16.0. Learn More on SELLAS Life Sciences Group's short interest ratio. Is SELLAS Life Sciences Group's short interest increasing or decreasing? SELLAS Life Sciences Group saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 8,610,000 shares, an increase of 41.6% from the previous total of 6,080,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does SELLAS Life Sciences Group's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to SELLAS Life Sciences Group: Kamada Ltd. (0.09%), Q32 Bio Inc. (15.96%), biote Corp. (2.70%), AC Immune SA (1.59%), Jasper Therapeutics, Inc. (15.20%), Aclaris Therapeutics, Inc. (3.37%), Cryoport, Inc. (6.10%), COMPASS Pathways plc (7.97%), Design Therapeutics, Inc. (8.07%), Sage Therapeutics, Inc. (11.91%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short SELLAS Life Sciences Group stock? Short selling SLS is an investing strategy that aims to generate trading profit from SELLAS Life Sciences Group as its price is falling. SLS shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against SELLAS Life Sciences Group? A short squeeze for SELLAS Life Sciences Group occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SLS, which in turn drives the price of the stock up even further. How often is SELLAS Life Sciences Group's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SLS, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies KMDA Short Interest Data QTTB Short Interest Data BTMD Short Interest Data ACIU Short Interest Data JSPR Short Interest Data ACRS Short Interest Data CYRX Short Interest Data CMPS Short Interest Data DSGN Short Interest Data SAGE Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SLS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SELLAS Life Sciences Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SELLAS Life Sciences Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SLS Stock Alerts